Last reviewed · How we verify
EMD525797
At a glance
| Generic name | EMD525797 |
|---|---|
| Sponsor | Merck KGaA, Darmstadt, Germany |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EMD525797 CI brief — competitive landscape report
- EMD525797 updates RSS · CI watch RSS
- Merck KGaA, Darmstadt, Germany portfolio CI